Forward Citations = 3

Loading Chart...

3 inventors (with patents filed for the assignee):

Paul DaSilva-Jardine (5 out of 5 patents)

Hans De Haard (5 out of 20 patents)

James A Landro (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 11248042 - Polynucleotides encoding anti-ApoC3 antibodies (2022-02-15),

2. 11248041 - Anti-ApoC3 antibodies (2022-02-15),

3. 11242381 - Anti-ApoC3 antibodies and methods of use thereof (2022-02-08),

4. 11091539 - Anti-ApoC3 antibodies and methods of use thereof (2021-08-17),

5. 10538583 - Anti-APOC3 antibodies and compositions thereof (2020-01-21),

Staten Biotechnology B.v. is a biotechnology company that focuses on the development of novel therapeutics for the treatment of cancer and other diseases. The company is dedicated to advancing innovative research and leveraging cutting-edge technology to bring new and improved treatment options to patients. With a team of experienced scientists and researchers, Staten Biotechnology is committed to making a positive impact on healthcare worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#15 in Nijmegen

#1,104 in Netherlands

Nijmegen, Netherlands

Staten Biotechnology B.v.

Forward Citations = 3

3 inventors:

Paul DaSilva-Jardine (5 out of 5 patents)

Hans De Haard (5 out of 20 patents)

James A Landro (1 out of 2 patents)

Please report any incorrect information to support@idiyas.com